131 related articles for article (PubMed ID: 8009256)
1. Use of the bisphosphonate space in treatment and retreatment of Paget's disease.
Stone MD; Patel S; Hosking DJ
Semin Arthritis Rheum; 1994 Feb; 23(4):278. PubMed ID: 8009256
[No Abstract] [Full Text] [Related]
2. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
Fritz P; Lioté F; Kuntz D
Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
[No Abstract] [Full Text] [Related]
3. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC
Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
[No Abstract] [Full Text] [Related]
4. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
Grauer A; Klar B; Scharla SH; Zieglar R
Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
[No Abstract] [Full Text] [Related]
5. Effects of intravenous aminopropylidene bisphosphonate in patients with refractory Paget's disease.
Cormier C; Hilliquin P; Menkès CJ
Br J Rheumatol; 1993 Aug; 32(8):767-8. PubMed ID: 8348290
[No Abstract] [Full Text] [Related]
6. Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
Sharp CA; Worsfold M; Rowlands PR; Davie MW
Semin Arthritis Rheum; 1994 Feb; 23(4):242-3. PubMed ID: 8009239
[No Abstract] [Full Text] [Related]
7. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
Heynen G; Delwaide P; Bijvoet OL; Franchimont P
Eur J Clin Invest; 1982 Feb; 12(1):29-35. PubMed ID: 6802650
[No Abstract] [Full Text] [Related]
8. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
Ismail AA; Fox P; Stamp TC; Dhillon V; Crisp AJ; MacGregor A
J Rheumatol; 1997 Nov; 24(11):2266-7. PubMed ID: 9375899
[No Abstract] [Full Text] [Related]
10. Intravenous pamidronate: evolution of an effective treatment strategy.
Anderson DC; Richardson PC; Brown JK; Freemont AJ; Hollis S; Denton J; Buckler HM; Hargreaves S; Cantrill JA
Semin Arthritis Rheum; 1994 Feb; 23(4):273-5. PubMed ID: 8009254
[No Abstract] [Full Text] [Related]
11. Effects of intravenous pamidronate therapy on Paget's disease of bone.
Bombassei GJ; Yocono M; Raisz LG
Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
[TBL] [Abstract][Full Text] [Related]
12. [Paget's disease and its therapeutic management].
Orcel P; Rousière M
Presse Med; 2005 Apr; 34(8):612-6. PubMed ID: 15962504
[TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
[TBL] [Abstract][Full Text] [Related]
14. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC
Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of resistant Paget's disease of bone with pamidronate.
Mallette LE
Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
[TBL] [Abstract][Full Text] [Related]
16. Paget's disease and bisphosphonates.
Rendina D; De Filippo G; Mossetti G
N Engl J Med; 2005 Dec; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
[No Abstract] [Full Text] [Related]
17. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V
Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
[TBL] [Abstract][Full Text] [Related]
18. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL
Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987
[TBL] [Abstract][Full Text] [Related]
19. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
Thiébaud D; Jaeger P; Gobelet C; Jacquet AF; Burckhardt P
Am J Med; 1988 Aug; 85(2):207-12. PubMed ID: 3261129
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
